Abstract:Sulfated polysaccharides such as heparin and heparan sulfate glycosaminoglycans (HSGAGs) are chemically and structurally heterogeneous biopolymers that that function as key regulators of numerous biological functions. The elucidation of HSGAG fine structure is fundamental to understanding their functional diversity, and this is facilitated by the use of select degrading enzymes of defined substrate specificity. Our previous studies have reported the cloning, characterization, recombinant expression, and structure-function analysis in Escherichia coli of the Flavobacterium heparinum 2-O-sulfatase and 6-O-sulfatase enzymes that cleave O-sulfate groups from specific locations of the HSGAG polymer. Building on these preceding studies, we report here the molecular cloning and recombinant expression in Escherichia coli of an N-sulfamidase, specific for HSGAGs. In addition, we examine the basic enzymology of this enzyme through molecular modeling studies and structure-function analysis of substrate specificity and basic biochemistry. We use the results from these studies to propose a novel mechanism for nitrogen-sulfur bond cleavage by the N-sulfamidase. Taken together, our structural and biochemical studies indicate that N-sulfamidase is a predominantly exolytic enzyme that specifically acts on N-sulfated and 6-O-desulfated glucosamines present as monosaccharides or at the nonreducing end of odd-numbered oligosaccharide substrates. In conjunction with the previously reported specificities for the F. heparinum 2-O-sulfatase, 6-O-sulfatase, and unsaturated glucuronyl hydrolase, we are able to now reconstruct in vitro the defined exolytic sequence for the heparin and heparan sulfate degradation pathway of F. heparinum and apply these enzymes in tandem toward the exo-sequencing of heparin-derived oligosaccharides.

Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido- -D-glucopyranose (1,4) 2-O-sulfo- -L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages

Periodic bifurcation from families of periodic solutions for semilinear differential equations with Lipschitzian perturbations in Banach spaces

Specificity studies on the heparin lyases from Flavobacterium heparinum

Enzymatic access to the rare ΔUA (1→4) Glc 3, 6, N-sulfated heparin disaccharide, implications for heparin quality control

Heparinase Digestion-Based Disaccharide Composition Analysis of Heparin and Heparinoid Drugs

Heparinase Digestion-based Disaccharide Analysis of Clinical Heparin and Heparinoids Drug

Sequencing analysis of heparin reducing terminals with orthogonal chromatographic approaches

Structure-based engineering of heparinase I with improved specific activity for degrading heparin

Identification and characterization of a novel heparinase PCHepII from marine bacterium Puteibacter caeruleilacunae

Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage

Identification of a hexasaccharide sequence able to inhibit thrombin and suitable for 'polymerisation'

The 3- O-sulfation of heparan sulfate modulates protein binding and lyase degradation

Chemical O-sulfation of N-sulfoheparosan: a Route to Rare N-sulfo-3-O-sulfoglucosamine and 2-O-sulfoglucuronic Acid.

Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase

Analysis of heparinase derived LMWH products using a MHC 2D LC system linked to Q-TOF MS

Production of Heparin Oligosaccharides by Fusion Protein of MBP–heparinase I and the Enzyme Thermostability

Surface plasmon resonance analysis to evaluate the importance of heparin sulfate groups' binding with human aFGF and bFGF

Characterization of Maltose-Binding Protein-Fused Heparinases with Enhanced Thermostability by Application of Rigid and Flexible Linkers

Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation

Catalytic Effects of Different Heparin Analogs on the Hydrolysis of Auramine O.

Structurally defined heparin octasaccharide domain for binding to SARS-CoV-2 Omicron BA.4/BA.5/BA.5.2 spike protein RBD